Episode Details

Back to Episodes
Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer

Episode 193 ESMO 2022: PRESTO - a phase III trial of androgen annihilation in biochemically relapsed prostate cancer

Season 1 Episode 193 Published 4 years, 1 month ago
Description
Rahul Aggarwal describes the results of this randomised phase III study.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us